RxDoctor Payments Data

Jennifer Compton

Physician Assistant · Kingsport, TNNPI 1467457341

Payments from drug & device makers

$5,321in general payments, 2019–2025

Across 383 payments — averaging $13.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$981
  • Novo Nordisk$773
  • Pfizer$374
  • Lilly USA, LLC$353
  • AstraZeneca$299
  • Bayer$274
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$5,321100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,321 in reported general payments places this provider in the 90th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$69,667
Medicare patients
185
Services billed
1,225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide103$108,057
EliquisApixaban48$57,983
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$22,730
JardianceEmpagliflozin23$20,257
XareltoRivaroxaban23$20,158
MounjaroTirzepatide19$19,048
FarxigaDapagliflozin Propanediol12$16,747
Nurtec OdtRimegepant Sulfate12$15,922
TrulicityDulaglutide12$13,036
LinzessLinaclotide11$8,960
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$7,586
MyrbetriqMirabegron13$7,444
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$3,993
Metoprolol Succinate175$3,430
Duloxetine Hcl63$3,351

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$773$108,057103 claims
PfizerEliquis, Nurtec Odt$374$73,90560 claims
Lilly USA, LLCMounjaro, Trulicity$353$32,08431 claims
GSKTrelegy Ellipta$250$22,73022 claims
Boehringer IngelheimJardiance$83$20,25723 claims
Johnson & JohnsonXarelto$18$20,15823 claims
AstraZenecaFarxiga, Symbicort$299$20,08026 claims
AbbVieLinzess$981$8,96011 claims
Astellas Pharma US IncMyrbetriq$103$7,44413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →